UROwebinar: Patient stratification and risk related treatment of NMIBC

UROwebinar: Handling adverse events after intravesical instillations in NMIBCПодробнее

UROwebinar: Overtreatment and oversurveillance for low grade NMIBCПодробнее

Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder CancerПодробнее

Expert video report on the management of patients with high-risk non-muscle invasive bladder cancerПодробнее

Very high risk non-muscle-invasive bladder cancer (NMIBC) in the current landscape of NMIBCПодробнее

Urowebinar: Identification and management of patients with nmCRPCПодробнее

UROWebinar: New insights in treatment of bladder cancer From localized to metastatic diseasesПодробнее

Urowebinar: New treatments development in NMIBCПодробнее

Bladder Cancer Risk Stratification: Moving from the Old to the NewПодробнее

Urowebinar: Practical management of bladder cancerПодробнее

UROwebinar: Difficult bladder cancer casesПодробнее

Urowebinar: Treatment strategy in muscle invasive bladder cancerПодробнее

UROwebinar: Imaging and PSA assessment in nmCRPC patients and the treatment consequencesПодробнее

Risk Stratified Management of nMIBC - EMPIRE Urology Lecture SeriesПодробнее

Risk Stratification in NMIBC and Classification of Low-Grade, Intermediate-Risk DiseaseПодробнее

Controversies in Non-muscle Invasive Bladder Cancer (NMIBC): Guidelines and Beyond 2023Подробнее

Urowebinar: Is immune therapy changing the way we think about early bladder cancer?Подробнее

UROwebinar: Management of nmCRPC: Putting current evidenceПодробнее

UROwebinar: Management of nmCRPC: Putting current evidence into practiceПодробнее